Biomrieux Sa Stock Buy Hold or Sell Recommendation
| BMXMF Stock | USD 105.67 0.02 0.02% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding bioMrieux SA is 'Hold'. Macroaxis provides BioMrieux buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BMXMF positions. The advice algorithm takes into account all of BioMrieux's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BioMrieux's buy or sell advice are summarized below:
Real Value 107.36 | Hype Value 105.67 | Market Value 105.67 | Naive Value 100.13 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell bioMrieux SA given historical horizon and risk tolerance towards BioMrieux. When Macroaxis issues a 'buy' or 'sell' recommendation for bioMrieux SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
BioMrieux |
Execute BioMrieux Buy or Sell Advice
The BioMrieux recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on bioMrieux SA. Macroaxis does not own or have any residual interests in bioMrieux SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioMrieux's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BioMrieux Trading Alerts and Improvement Suggestions
| bioMrieux SA generated a negative expected return over the last 90 days | |
| About 64.0% of the company shares are held by company insiders |
BioMrieux Returns Distribution Density
The distribution of BioMrieux's historical returns is an attempt to chart the uncertainty of BioMrieux's future price movements. The chart of the probability distribution of BioMrieux daily returns describes the distribution of returns around its average expected value. We use bioMrieux SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioMrieux returns is essential to provide solid investment advice for BioMrieux.
| Mean Return | -0.09 | Value At Risk | -2.97 | Potential Upside | 1.91 | Standard Deviation | 2.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioMrieux historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioMrieux Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioMrieux or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioMrieux's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioMrieux pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.13 | |
β | Beta against NYSE Composite | 0.34 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | -0.08 |
BioMrieux Volatility Alert
bioMrieux SA exhibits very low volatility with skewness of 1.99 and kurtosis of 15.85. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioMrieux's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioMrieux's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioMrieux Fundamentals Vs Peers
Comparing BioMrieux's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioMrieux's direct or indirect competition across all of the common fundamentals between BioMrieux and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioMrieux or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BioMrieux's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioMrieux by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioMrieux to competition |
| Fundamentals | BioMrieux | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.1 | -0.14 |
| Profit Margin | 0.16 % | (1.27) % |
| Operating Margin | 0.21 % | (5.51) % |
| Current Valuation | 11.99 B | 16.62 B |
| Shares Outstanding | 118.37 M | 571.82 M |
| Shares Owned By Insiders | 64.28 % | 10.09 % |
| Shares Owned By Institutions | 18.40 % | 39.21 % |
| Price To Earning | 23.91 X | 28.72 X |
| Price To Book | 3.18 X | 9.51 X |
| Price To Sales | 3.63 X | 11.42 X |
| Revenue | 3.38 B | 9.43 B |
| Gross Profit | 1.96 B | 27.38 B |
| EBITDA | 1.01 B | 3.9 B |
| Net Income | 601.1 M | 570.98 M |
| Cash And Equivalents | 524.2 M | 2.7 B |
| Cash Per Share | 4.43 X | 5.01 X |
| Total Debt | 362.8 M | 5.32 B |
| Debt To Equity | 0.17 % | 48.70 % |
| Current Ratio | 2.02 X | 2.16 X |
| Book Value Per Share | 29.31 X | 1.93 K |
| Cash Flow From Operations | 811.1 M | 971.22 M |
| Earnings Per Share | 4.99 X | 3.12 X |
| Price To Earnings To Growth | 2.84 X | 4.89 X |
| Number Of Employees | 12.08 K | 18.84 K |
| Beta | 0.16 | -0.15 |
| Market Capitalization | 12.05 B | 19.03 B |
| Total Asset | 4.62 B | 29.47 B |
| Retained Earnings | 86 M | 9.33 B |
| Working Capital | 412 M | 1.48 B |
| Current Asset | 1.06 B | 9.34 B |
| Current Liabilities | 644 M | 7.9 B |
| Z Score | 19.8 | 8.72 |
BioMrieux Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioMrieux . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 105.67 | |||
| Day Typical Price | 105.67 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
About BioMrieux Buy or Sell Advice
When is the right time to buy or sell bioMrieux SA? Buying financial instruments such as BioMrieux Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioMrieux in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Top Crypto Assets Thematic Idea Now
Top Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in null. The Top Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out BioMrieux Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for BioMrieux Pink Sheet analysis
When running BioMrieux's price analysis, check to measure BioMrieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioMrieux is operating at the current time. Most of BioMrieux's value examination focuses on studying past and present price action to predict the probability of BioMrieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioMrieux's price. Additionally, you may evaluate how the addition of BioMrieux to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |